AL·Async + video
Telehealth · CO
Colorado
Colorado residents can now access GLP-1 medications like semaglutide and tirzepatide through telehealth — from Denver and the Front Range to mountain towns and the Western Slope. Pallas Health connects you with a board-certified provider licensed in Colorado who can evaluate your eligibility in under 5 minutes and, if appropriate, prescribe medication that ships to any Colorado address in a few business days.
- Licensed by
- Colorado Medical Board
- Telehealth
- Async + video
- Compounded semaglutide
- Available
- Compounded tirzepatide
- Available
- Medicaid
- Limited coverage
- Shipping
- 2–3 business days
How telehealth prescribing works in Colorado
Colorado permits licensed providers to use telehealth to establish a patient relationship and prescribe non-controlled medications like GLP-1s, including synchronous video and, in appropriate cases, asynchronous review when the standard of care is met.
Colorado requires any provider writing a prescription to a Colorado resident to hold an active Colorado medical license — out-of-state licensure is not sufficient. Under C.R.S. § 12-240-138 and Colorado Medical Board telehealth policy, licensed providers may use telemedicine to establish the provider-patient relationship and prescribe non-controlled medications, including via synchronous video and, in appropriate cases, asynchronous review when the standard of care is met. Colorado is also a full member of the Interstate Medical Licensure Compact (IMLC), which streamlines licensure for qualifying providers but does not waive the Colorado-license requirement to treat Colorado patients. Every Pallas clinician who treats Colorado patients is individually licensed by the Colorado Medical Board. GLP-1s are not controlled substances, so Colorado's separate Prescription Drug Monitoring Program and controlled-substance telemedicine requirements don't add friction here, but our providers still document a complete history, screen for contraindications like personal or family history of medullary thyroid carcinoma, and schedule follow-up visits to monitor response and titrate the dose.
Medicaid & insurance in Colorado
Limited coverage
Health First Colorado (Colorado Medicaid) covers GLP-1s for type 2 diabetes with prior authorization. Coverage for weight-management indications is limited. Compounded GLP-1s are not covered.
Pallas is a cash-pay telehealth service. Medicaid and private insurance do not apply to our prescriptions; pricing is flat and disclosed up front.
Simple cash-pay pricing in Colorado
No insurance, and the same price in every Colorado ZIP code. You see your full price during intake, before you pay anything.
Compounded plans · provider care included
- Compounded semaglutide$139 first month, then $597 every 12 weeks ($199/mo avg)
- Compounded tirzepatide$179 first month, then $897 every 12 weeks ($299/mo avg)
Your plan price covers your US-licensed provider, ongoing check-ins, dose adjustments, and unlimited care-team messaging — no separate membership fee. Medication ships free and discreet, only if prescribed; refunded in full if a clinician decides treatment isn’t right for you. Cancel anytime. Pay-over-time options are available at checkout.
Brand-name · FDA-approved
FDA-approved Wegovy® and Zepbound® for chronic weight management, plus Ozempic® and Mounjaro® for type 2 diabetes, are available cash-pay from $1,069/mo. Your clinician helps determine which option is appropriate for you.
Pallas offers both FDA-approved and compounded medications. Compounded medications are not FDA-approved and are not generic versions of brand-name drugs. Eligibility and treatment are determined by a US-licensed clinician; results vary. Private pay only (no insurance). Operated by Brentmoor, Inc.
Semaglutide vs tirzepatide in Colorado
Both are once-weekly injections available to Colorado patients through Pallas, as compounded preparations and as the FDA-approved brand-name products. They work differently: semaglutide activates the GLP-1 receptor, while tirzepatide activates both the GLP-1 and GIP receptors — two of the gut hormones that regulate appetite and fullness.
In SURMOUNT-5, the head-to-head clinical trial of the FDA-approved products, Zepbound® (tirzepatide) produced greater average weight loss than Wegovy® (semaglutide) — roughly 20% versus 14% of body weight over 72 weeks — with broadly similar tolerability. Clinical trial outcomes for the FDA-approved products have not been established for compounded preparations. Individual results vary.
Cost and track record differ too: compounded semaglutide plans average $199/mo versus $299/mo for tirzepatide (full terms above), and semaglutide has the longer post-market record. Which medication fits your health history, goals, and budget is a decision you make with a clinician licensed in Colorado — our full semaglutide vs tirzepatide comparison covers the deeper differences.
Cities served in Colorado
We ship to every ZIP code in Colorado, including:
- Denver
- Colorado Springs
- Aurora
- Fort Collins
- Lakewood
- Thornton
- Arvada
- Boulder
Colorado GLP-1 questions
Yes. Colorado law allows a licensed Colorado provider to establish a patient relationship and prescribe non-controlled medications like semaglutide and tirzepatide through telehealth, including asynchronous review of your intake when the standard of care is met.
Health First Colorado covers GLP-1s for type 2 diabetes with prior authorization. Coverage for weight-management indications is limited. Compounded GLP-1s are not covered. Pallas is a cash-pay telehealth service, so Medicaid rules do not affect our pricing.
Yes. Compounded semaglutide prescribed by a Colorado-licensed provider and dispensed by a licensed compounding pharmacy is legal when prepared for a specific patient with a documented clinical need. Pallas works only with U.S. state-licensed 503A and 503B compounding pharmacies.
Most Colorado patients receive their medication within 2–3 business days of the pharmacy filling the prescription. Denver, Boulder, Colorado Springs, and the Front Range typically ship fastest; mountain and Western Slope ZIP codes may take an extra day.
Compounded semaglutide injection through Pallas is $139 for your first month, then $597 every 12 weeks ($199/mo average). Cancel anytime. That one plan price includes your US-licensed provider, ongoing check-ins, dose adjustments, and unlimited care-team messaging — no separate membership fee. Medication ships free to any Colorado address, only if a clinician prescribes it, and you are refunded in full if a clinician decides treatment isn't right for you.
Compounded tirzepatide injection through Pallas is $179 for your first month, then $897 every 12 weeks ($299/mo average). Cancel anytime. That one plan price includes your US-licensed provider, ongoing check-ins, dose adjustments, and unlimited care-team messaging — no separate membership fee. Medication ships free to any Colorado address, only if a clinician prescribes it, and you are refunded in full if a clinician decides treatment isn't right for you.
Yes. FDA-approved Wegovy® and Zepbound® for chronic weight management — plus Ozempic® and Mounjaro® for type 2 diabetes — are available to Colorado patients cash-pay from $1069/mo; insurance is not billed. Whether a brand-name or compounded medication is appropriate for you is determined by a clinician licensed in Colorado during intake.
That is a decision you make with your clinician. Semaglutide activates the GLP-1 receptor; tirzepatide activates both the GLP-1 and GIP receptors. In the SURMOUNT-5 head-to-head trial of the FDA-approved products, Zepbound® (tirzepatide) produced greater average weight loss than Wegovy® (semaglutide) — about 20% versus 14% of body weight over 72 weeks. Clinical trial outcomes for the FDA-approved products have not been established for compounded preparations. Individual results vary. Semaglutide plans cost less and semaglutide has the longer post-market record; a clinician licensed in Colorado weighs your history, goals, and budget to recommend a starting point.
Start your Colorado intake